Drugs / Acthrel
Acthrel
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | ACTHREL | — | 1996-05-23 | fda.gov ↗ |
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01673087 | Oct 2012 → Aug 2017 | — | University of Michigan | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01373372 | Dec 2016 | dyspepsia | Children's Mercy Hospital Kansas City | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acthrel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01373372 ↗ |
| Known as | Corticorelin | “Acthrel® (brand name for Corticorelin)” NCT01373372 ↗ |
| Known as | Corticorelin ovine triflutate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01673087 ↗ |
| Route | Intravenous | “delivered one time via IV over one minute” NCT01373372 ↗ |